The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Open accessAbstract
Summary: Parkinson disease (PD) is a chronic neurodegenerative disorder with a cumulative prevalence of greater than one per thousand. To date three independent genome‐wide association studies (GWAS) have investigated the genetic susceptibility to PD. These studies implicated several genes as PD risk loci with strong, but not genome‐wide significant, associations. In this study, we combined data from two previously published GWAS of Caucasian subjects with our GWAS of 604 cases and 619 controls for a joint analysis with a combined sample size of 1752 cases and 1745 controls. SNPs in SNCA (rs2736990, p‐value = 6.7 × 10−8; genome‐wide adjusted p = 0.0109, odds ratio (OR) = 1.29 [95% CI: 1.17–1.42] G vs. A allele, population attributable risk percent (PAR%) = 12%) and the MAPT region (rs11012, p‐value = 5.6 × 10−8; genome‐wide adjusted p = 0.0079, OR = 0.70 [95% CI: 0.62–0.79] T vs. C allele, PAR%= 8%) were genome‐wide significant. No other SNPs were genome‐wide significant in this analysis. This study confirms that SNCA and the MAPT region are major genes whose common variants are influencing risk of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 5×
“25 were chosen using PLINK (Purcell et al., 2007) with an r2 threshold of 0.”
MethodInfluentialInference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,908
Detecting the number of clusters of individuals using the software structure: a simulation study
EVANNO, G., REGNAUT, S., & GOUDET, J. (2005) · Molecular Ecology · doi:10.1111/j.1365-294x.2005.02553.x · Cited by 21,895
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 2×
“Tel: 305-243-2372; Fax: 305-243-1968; E-mail: Emartin1@med.miami.edu effects in relatively rare, early-onset, Mendelian forms of PD (Polymeropoulos et al., 1997; Kitada et al., 1998; Bonifati et al., 2003; Paisan-Ruiz et al., 2004; Zimprich et al., 2004).”
BackgroundFalush, D., Stephens, M., & Pritchard, J. K. (2003) · Genetics · doi:10.1093/genetics/164.4.1567 · Cited by 7,959
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
ROGERS, S. M., & BERNATCHEZ, L. (2005) · Molecular Ecology · doi:10.1111/j.1365-294x.2004.02396.x · Cited by 5,088
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
A new multipoint method for genome-wide association studies by imputation of genotypes
Marchini, J., Howie, B., Myers, S., McVean, G., & Donnelly, P. (2007) · Nature Genetics · doi:10.1038/ng2088 · Cited by 2,609
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.6.734 · Cited by 2,117
Tests for Linear Trends in Proportions and Frequencies
Armitage, P. (1955) · Biometrics · doi:10.2307/3001775 · Cited by 2,071
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 2×
“which may provide some insight into PD pathology as previous studies have shown that tau mediates and promotes the polymerisation of AS (Giasson et al., 2003).”
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
A common inversion under selection in Europeans
Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., Baker, A., Jonasdottir, A., Ingason, A., Gudnadottir, V. G., et al. (2005) · Nature Genetics · doi:10.1038/ng1508 · Cited by 828
Epidemiology: Study Design and Data Analysis
(2006) · Technometrics · doi:10.1198/tech.2006.s407 · Cited by 788
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.935 · Cited by 724
A genome-wide scalable SNP genotyping assay using microarray technology
Gunderson, K. L., Steemers, F. J., Lee, G., Mendoza, L. G., & Chee, M. S. (2005) · Nature Genetics · doi:10.1038/ng1547 · Cited by 654
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373937 · Cited by 537
Self-citationHigh-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
Litvan, I., Hauw, J. J., Bartko, J. J., Lantos, P. L., Daniel, S. E., Horoupian, D. S., McKee, A., Dickson, D., Bancher, C., Tabaton, M., et al. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199601000-00010 · Cited by 475
Type 2 Diabetes and the Risk of Parkinson's Disease
Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443
Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
Okazaki, H., Lipkin, L. E., & Aronson, S. M. (1961) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196104000-00007 · Cited by 301
Complete Genomic Screen in Parkinson Disease: Evidence for Multiple Genes
Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K., Pahwa, R., Stern, M. B., Colcher, A., Hiner, B. C., et al. (2001) · JAMA · doi:10.1001/jama.286.18.2239 · Cited by 282
Self-citationKr�ger, R., Menezes Vieira-Saecker, A. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x · Cited by 277
Pittman, A. M., Myers, A. J., Abou-Sleiman, P., Fung, H. C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031377 · Cited by 272
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21192 · Cited by 270
Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer Disease
Beecham, G. W., Martin, E. R., Li, Y.-J., Slifer, M. A., Gilbert, J. R., Haines, J. L., & Pericak-Vance, M. A. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.008 · Cited by 260
Self-citationMolecular Genetics of Successful Smoking Cessation: Convergent Genome-Wide Association Study Results
Uhl, G. R., Liu, Q.-R., Drgon, T., Johnson, C., Walther, D., Rose, J. E., David, S. P., Niaura, R., & Lerman, C. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.683 · Cited by 237
Going new places using an old MAP: tau, microtubules and human neurodegenerative disease
Garcia, M. L., & Cleveland, D. W. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00172-1 · Cited by 235
Multiple regions of α‐synuclein are associated with Parkinson's disease
Mueller, J. C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T., & Gasser, T. (2005) · Annals of Neurology · doi:10.1002/ana.20438 · Cited by 234
Tobacco Consumption and Mortality from Cancer and Other Diseases
Dorn, H. F. (1959) · Public Health Reports (1896-1970) · doi:10.2307/4590516 · Cited by 228
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians
Ghezzi, D., Marelli, C., Achilli, A., Goldwurm, S., Pezzoli, G., Barone, P., Pellecchia, M. T., Stanzione, P., Brusa, L., Bentivoglio, A. R., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201425 · Cited by 205
Smoking and Parkinson's disease: Systematic review of prospective studies
Allam, M. F., Campbell, M. J., Hofman, A., Del Castillo, A. S., & Fernández‐Crehuet Navajas, R. (2004) · Movement Disorders · doi:10.1002/mds.20029 · Cited by 192
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
Martin, E. R. (2001) · JAMA · doi:10.1001/jama.286.18.2245 · Cited by 191
Self-citationTau gene mutations: dissecting the pathogenesis of FTDP-17
Ingram, E. M., & Spillantini, M. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02440-1 · Cited by 177
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C., Keers, S. M., Allcock, L. M., Davison, J., Lewis, S. J., Perry, R. H., Barker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20417 · Cited by 176
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., & Logroscino, G. (2008) · Diabetes Care · doi:10.2337/dc08-0688 · Cited by 168
Association of a monoamine oxidase B allele with Parkinson's disease
Kurth, J. H., Kurth, M. C., Poduslo, S. E., & Schwankhaus, J. D. (1993) · Annals of Neurology · doi:10.1002/ana.410330406 · Cited by 166
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease
Zabetian, C. P., Hutter, C. M., Factor, S. A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Kay, D. M., Yearout, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21157 · Cited by 165
Tau haplotypes regulate transcription and are associated with Parkinson's disease
Kwok, J. B. J., Teber, E. T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G. D., Buchanan, D. D., Silburn, P. A., & Schofield, P. R. (2004) · Annals of Neurology · doi:10.1002/ana.10826 · Cited by 159
Linkage Disequilibrium and Association of MAPT H1 in Parkinson Disease
Skipper, L., Wilkes, K., Toft, M., Baker, M., Lincoln, S., Hulihan, M., Ross, O. A., Hutton, M., Aasly, J., & Farrer, M. (2004) · The American Journal of Human Genetics · doi:10.1086/424492 · Cited by 158
Presenile dementia with Alzheimer-, Pick- and Lewy-body changes
Kosaka, K., Oyanagi, S., Matsushita, M., Hori, A., & Iwase, S. (1976) · Acta Neuropathologica · doi:10.1007/bf00685366 · Cited by 148
Oki, T., Yamazaki, K., Kuromitsu, J., Okada, M., & Tanaka, I. (1999) · Genomics · doi:10.1006/geno.1999.5785 · Cited by 143
Changing epidemiology of Parkinson’s disease in southwestern Finland
Kuopio, A., Marttila, R. J., Helenius, H. Y. M., & Rinne, U. K. (1999) · Neurology · doi:10.1212/wnl.52.2.302 · Cited by 137
Tau gene and Parkinson's disease: a case-control study and meta-analysis
Healy, D. G., Abou-Sleiman, P. M., Lees, A. J., Casas, J. P., Quinn, N., Bhatia, K., Hingorani, A. D., & Wood, N. W. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.026203 · Cited by 127
Habuchi, T., Luscombe, M., Elder, P. A., & Knowles, M. A. (1998) · Genomics · doi:10.1006/geno.1997.5165 · Cited by 126
Finnil�, S., Autere, J. M., Moilanen, J. S., Soininen, H. S., Mannermaa, A., Hartikainen, P., Hallikainen, M., & Majamaa, K. (2004) · Human Genetics · doi:10.1007/s00439-004-1123-9 · Cited by 123
Ross, O. A. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00266-8 · Cited by 107
Exploring gene-environment interactions in Parkinson’s disease
McCulloch, C. C., Kay, D. M., Factor, S. A., Samii, A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Montimurro, J. S., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0466-z · Cited by 100
Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population
Huerta, C., Castro, M. G., Coto, E., Estrada, M. B., Ribacoba, R., Guisasola, L. M., Salvador, C., Martínez, C., Lahoz, C. H., & Álvarez, V. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.04.016 · Cited by 96
Mitochondria and Neurodegeneration
Beal, M. F. (2007) · Novartis Foundation symposium · doi:10.1002/9780470725207.ch13 · Cited by 96
Validation of a Telephone Questionnaire for Parkinson’s Disease
Rocca, W. A., Maraganore, D. M., McDonnell, S. K., & Schaid, D. J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00017-1 · Cited by 87
Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease
Kösel, S., Grasbon-Frodl, E. M., Mautsch, U., Egensperger, R., Eitzen, U. V., Frishman, D., Hofmann, S., Gerbitz, K.-D., Mehraein, P., & Graeber, M. B. (1998) · Neurogenetics · doi:10.1007/s100480050029 · Cited by 86
Zhang, H., Jia, Y., Cooper, J. J., Hale, T. C., Zhang, Z., & Elbein, S. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031286 · Cited by 82
Identification of Risk and Age-at-Onset Genes on Chromosome 1p in Parkinson Disease
Oliveira, S. A., Li, Y., Noureddine, M., Zuchner, S. L., Qin, X., Pericak‐Vance, M. A., & Vance, J. M. (2005) · The American Journal of Human Genetics · doi:10.1086/432588 · Cited by 80
Self-citationAssociation between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease
Noureddine, M. A., Qin, X.-J., Oliveira, S. A., Skelly, T. J., van der Walt, J., Hauser, M. A., Pericak-Vance, M. A., Vance, J. M., & Li, Y.-J. (2005) · Human Genetics · doi:10.1007/s00439-005-1259-2 · Cited by 76
Self-citationMyhre, R., Toft, M., Kachergus, J. M., Hulihan, M., Aasly, J. O., Klungland, H., & Farrer, M. J. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01019.x · Cited by 74
Rubinsztein, D. C., Hanlon, C., Irving, R. M., Goodburn, S. F., Evans, D. G., Keller-Wood, H., Xuereb, J. H., Bandmann, O., & Harding, A. E. (1994) · Molecular and Cellular Probes · doi:10.1006/mcpr.1994.1073 · Cited by 73
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease
Vandrovcová, J., Pittman, A. M., Malzer, E., Abou‐Sleiman, P. M., Lees, A. J., Wood, N. W., & de Silva, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.019 · Cited by 72
The Tau H1 Haplotype is associated with Parkinson's disease in the Norwegian population
Farrer, M. J., Skipper, L. M., Berg, M., Bisceglio, G. D., Hanson, M., Hardy, J., Adam, A., Gwinn, K. A., & Aasly, J. O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00106-4 · Cited by 69
Li, Y., Schrodi, S. J., Rowland, C. M., Tacey, K. M., Catanese, J. J., & Grupe, A. (2006) · Human Mutation · doi:10.1002/humu.20382 · Cited by 67
The tau A0 allele in Parkinson's disease
Golbe, L. I., Lazzarini, A. M., Spychala, J. R., Johnson, W. G., Stenroos, E. S., Mark, M. H., & Sage, J. I. (2001) · Movement Disorders · doi:10.1002/mds.1087 · Cited by 66
Gawęda-Walerych, K., Maruszak, A., Safranow, K., Białecka, M. A., Kłodowska-Duda, G. A., Czyźewski, K., Sławek, J. W., Rudzińska, M., Styczyńska, M., Opala, G., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0121-9 · Cited by 59
Negative regulation of G1/S transition by the candidate bladder tumour suppressor gene DBCCR1
Nishiyama, H., Gill, J. H., Pitt, E., Kennedy, W., & Knowles, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204432 · Cited by 59
Case‐control study of the extended tau gene haplotype in Parkinson's disease
Maraganore, D. M., Hernandez, D. G., Singleton, A., Farrer, M. J., McDonnell, S. K., Hutton, M. L., Hardy, J., & Rocca, W. A. (2001) · Annals of Neurology · doi:10.1002/ana.1228 · Cited by 55
Sutherland, G. T., Halliday, G. M., Silburn, P. A., Mastaglia, F. L., Rowe, D. B., Boyle, R. S., O’Sullivan, J. D., Ly, T., Wilton, S. D., & Mellick, G. D. (2009) · Movement Disorders · doi:10.1002/mds.22214 · Cited by 51
Interaction of α‐synuclein and tau genotypes in Parkinson's disease
Mamah, C., Lesnick, T. G., Lincoln, S., Strain, K. J., de Andrade, M., Bower, J. H., Ahlskog, J. E., Rocca, W. A., Farrer, M. J., & Maraganore, D. M. (2005) · Annals of Neurology · doi:10.1002/ana.20387 · Cited by 47
Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease
Wahner, A. D., Glatt, C. E., Bronstein, J. M., & Ritz, B. R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.053 · Cited by 45
Fung, H., Xiromerisiou, G., Gibbs, J. R., Wu, Y., Eerola, J., Gourbali, V., Hellström, O., Chen, C. M., Duckworth, J., Papadimitriou, A., et al. (2006) · Neurodegenerative Diseases · doi:10.1159/000097301 · Cited by 42
Replication of association between ELAVL4 and Parkinson disease: the GenePD study
DeStefano, A. L., Latourelle, J., Lew, M. F., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0526-4 · Cited by 40
Self-citationNOS2A and the modulating effect of cigarette smoking in Parkinson's disease
Hancock, D. B., Martin, E. R., Fujiwara, K., Stacy, M. A., Scott, B. L., Stajich, J. M., Jewett, R. M., Li, Y., Hauser, M. A., Vance, J. M., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20915 · Cited by 37
Self-citationEmerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2
Devine, M. J., & Lewis, P. A. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06707.x · Cited by 35
Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease
Winkler, S., König, I. R., Lohmann-Hedrich, K., Vieregge, P., Kostić, V., & Klein, C. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201901 · Cited by 33
Fine-mapping and candidate gene investigation within the PARK10 locus
Haugarvoll, K., Toft, M., Skipper, L. M., Heckman, M. G., Crook, J. E., Soto, A. I., Ross, O. A., Hulihan, M., Kachergus, J. M., Sando, S. B., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.187 · Cited by 33
Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease
Lévecque, C., Elbaz, A., Clavel, J., Vidal, J. S., Amouyel, P., Alpérovitch, A., Tzourio, C., & Chartier-Harlin, M. C. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.015750 · Cited by 28
Haugarvoll, K., Toft, M., Ross, O. A., Stone, J. T., Heckman, M. G., White, L. R., Lynch, T., Gibson, J. M., Wszolek, Z. K., Uitti, R. J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21336 · Cited by 26
Association of the Tau haplotype with Parkinson's disease in the Greek population
Fidani, L., Kalinderi, K., Bostantjopoulou, S., Clarimón, J., Goulas, A., Katsarou, Z., Hardy, J., & Kotsis, A. (2006) · Movement Disorders · doi:10.1002/mds.20864 · Cited by 26
Refenes, N., Bolbrinker, J., Tagaris, G. L., Orlacchio, A., Drakoulis, N., & Kreutz, R. H. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-26 · Cited by 18
DBC1 re-expression alters the expression of multiple components of the plasminogen pathway
Louhelainen, J., Hurst, C. D., Pitt, E., Nishiyama, H., Pickett, H. A., & Knowles, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209228 · Cited by 18
Cited by
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationMitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
The 23andMe Research Team, Jansen, P. R., Watanabe, K., Stringer, S., Skene, N., Bryois, J., Hammerschlag, A. R., de Leeuw, C. A., Benjamins, J. S., Muñoz-Manchado, A. B., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0333-3 · Cited by 857
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
Metadata
- Authors
- Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Züchner, S., Konidari, I., Wang, G., Singer, C., Nahab, F., Scott, B., Stajich, J. M., Pericak‐Vance, M., Haines, J., Vance, J. M., & Martin, E. R.
- Venue
- Annals of Human Genetics
- Publisher
- Wiley
- Published
- 2010-03
- Volume
- 74
- Issue
- 2
- Pages
- 97-109
- ISSN
- 0003-4800 (ISSN-L)
- 1469-1809
- OpenAlex
- W2018907079
- Cited by
- 465
- References
- 99
- FWCI
- 29.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.